Dr. Krishna Gundabolu, MBBS

Claim this profile

University of Nebraska

Studies Lymphoblastic Leukemia-Lymphoma
Studies Lymphoid Leukemia
4 reported clinical trials
17 drugs studied

Area of expertise

1Lymphoblastic Leukemia-Lymphoma
Krishna Gundabolu, MBBS has run 4 trials for Lymphoblastic Leukemia-Lymphoma. Some of their research focus areas include:
Stage I
Stage II
CD22 positive
2Lymphoid Leukemia
Krishna Gundabolu, MBBS has run 4 trials for Lymphoid Leukemia. Some of their research focus areas include:
Stage I
Stage II
CD22 positive

Affiliated Hospitals

Image of trial facility.
Nebraska Medicine-Village Pointe
Image of trial facility.
University Of Nebraska Medical Center

Clinical Trials Krishna Gundabolu, MBBS is currently running

Image of trial facility.

Inotuzumab + Blinatumomab

for Acute Lymphoblastic Leukemia

This phase II trial studies how well inotuzumab ozogamicin and blinatumomab work in treating patients with CD22-positive B-lineage acute lymphoblastic leukemia that is newly diagnosed, has come back, or does not respond to treatment. Immunotherapy with monoclonal antibodies, such as inotuzumab ozogamicin and blinatumomab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.
Recruiting1 award Phase 210 criteria

More about Krishna Gundabolu, MBBS

Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Krishna Gundabolu, MBBS has experience with
  • Inotuzumab Ozogamicin
  • WU-CART-007
  • Doxorubicin
  • Methotrexate
  • Rituximab
  • Pegylated L-Asparaginase
Breakdown of trials Krishna Gundabolu, MBBS has run
Lymphoblastic Leukemia-Lymphoma
Lymphoid Leukemia
Leukemia
Acute Lymphoblastic Leukemia
T-Cell Lymphoblastic Leukemia-Lymphoma

Other Doctors you might be interested in

Pavankumar TandraUniversity of Nebraska Medical Center
Laura L. TennerGSK Investigational Site
Jill C. BeckChildren's Hospital and Medical Center of Omaha

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Krishna Gundabolu, MBBS specialize in?
Krishna Gundabolu, MBBS focuses on Lymphoblastic Leukemia-Lymphoma and Lymphoid Leukemia. In particular, much of their work with Lymphoblastic Leukemia-Lymphoma has involved Stage I patients, or patients who are Stage II.
Is Krishna Gundabolu, MBBS currently recruiting for clinical trials?
Yes, Krishna Gundabolu, MBBS is currently recruiting for 1 clinical trial in Omaha Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Krishna Gundabolu, MBBS has studied deeply?
Yes, Krishna Gundabolu, MBBS has studied treatments such as Inotuzumab Ozogamicin, WU-CART-007, Doxorubicin.
What is the best way to schedule an appointment with Krishna Gundabolu, MBBS?
Apply for one of the trials that Krishna Gundabolu, MBBS is conducting.
What is the office address of Krishna Gundabolu, MBBS?
The office of Krishna Gundabolu, MBBS is located at: University of Nebraska, Omaha, Nebraska 68198 United States. This is the address for their practice at the University of Nebraska.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top